ArticleJournal of the Endocrine Society2026
Phenotyping and hierarchical clustering in genetically unresolved DSD identifies distinct multisystem clinical subgroups-a DSDgene study.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: A substantial proportion of individuals with differences of sex development (DSD) remain without an identifiable molecular diagnosis. Systematic phenotyping may reveal clinically relevant patterns and inform genomic investigation. Objective: To identify phenotypic patterns among individuals with genetically unresolved DSD and determine whether multisystem anomalies form distinct clinical clusters and exhibit overlap with established DSD-associated conditions. Design: Data from the I-DSD Registry were analyzed for individuals with 46,XY or 46,XX DSD lacking a molecular diagnosis. A 3-part approach was used: (1) unsupervised hierarchical clustering based on Gower distance; (2) supervised phenotype-guided classification using reference profiles for NR5A1/SF-1 deficiency and P450 oxidoreductase deficiency (PORD); and (3) exploratory comparison with Human Phenotype Ontology (HPO)-derived profiles of established DSD-associated genes. Results: Among 1391 screened individuals, 345 (24.8%) fulfilled inclusion criteria, including the presence of at least 1 additional organ anomaly, 83.8% had a 46,XY karyotype. The most frequent associated findings were small for gestational age (28.1%), cardiac anomalies (21.4%), central nervous system (CNS) (15.7%), and renal anomalies (14.5%). Unsupervised clustering identified 5 phenotypic groups, including craniofacial-dominant and CNS-dominant clusters. Phenotype-guided classification showed overlap with SF-1-deficiency-associated phenotypes in 11% of cases and with PORD-associated phenotypes in 22%. Comparison with HPO-derived profiles of 81 DSD-associated genes demonstrated phenotypic similarities between several clusters and known gene-associated anomaly spectra. Conclusion: Systematic phenotyping identifies recognizable patterns of multisystem involvement in genetically unresolved DSD. Several clusters overlap with established DSD-associated conditions and gene-specific anomaly profiles, supporting phenotype-driven surveillance, multidisciplinary care, and informing future genomic re-evaluation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.